title: [Comprehensive analysis of therapeutic methods and effect on cesarean scar pregnancy].
abstract: OBJECTIVE
  To evaluate the efficacies and medic economic efficiency of therapeutic method for cesarean scar pregnancy (CSP).
  
  
  METHODS
  The pertinent literatures on the treatment of CSP were collected and screened by retrieving some Chinese and English databases, such as PubMed, VIP and Wanfang Data. The weighting means and polled standard deviations of operative duration, operative hemorrhage volume, hysterectomy rate, length of stay, medical fees and the time of serum level of beta-human chorionic gonadotropin (β-HCG) returning to normal were reckoned.
  
  
  RESULTS
  Among different therapeutic methods of CSP, curettage duration was shortest in the patients with methotrexate (MTX) injection; operative hemorrhage volume, hysterectomy rate and length of stay were smallest in those with uterine artery embolization; medical fees was least in those with local MTX injection; the time of serum β-HCG level returning to normal was shortest in those with hysteroscopic and/or laparoscopic operation after MTX injection or uterine artery embolization.
  
  
  CONCLUSIONS
  Curettage after uterine artery embolization offers multiple advantages over therapeutic methods in the treatment of CSP.
authors.affiliation: Department of Obstetrics & Gynecology, Yuyao People's Hospital, Yuyao 315400, China. yyphshj@163.com
authors.forename: Hua-jiang
authors.initials: HJ
authors.lastname: Shao
authors.forename: Jian-ting
authors.initials: JT
authors.lastname: Ma
authors.forename: Li-ping
authors.initials: LP
authors.lastname: Xu
authors.forename: Chun-lin
authors.initials: CL
authors.lastname: Yang
authors.forename: Yun-que
authors.initials: YQ
authors.lastname: Fu
authors.forename: Xue-feng
authors.initials: XF
authors.lastname: Su
mesh_terms: D002585:Cesarean Section / Q000009:adverse effects; D002921:Cicatrix / Q000209:etiology; D005260:Female; D006801:Humans; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000175:diagnosis / Q000191:economics / Q000628:therapy*; D016896:Treatment Outcome